Dr. Michael R. Gold commented that in his experience, another important group of candidates for the wearable defibrillator are arrhythmia-prone patients who develop a cardiac device infection requiring device removal.
"You’re worried about that patient yet you can’t implant another device because it may take weeks or months to clear the infection," noted Dr. Gold, professor of medicine, chief of cardiology, and medical director of the heart and vascular center at the Medical University of South Carolina, Charleston.
Dr. Goldenberg reported having received research grants from Zoll Medical, which sponsors the WEARIT-II registry and markets the LifeVest, as well as from Boston Scientific.